Motohiro Shimizu

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 122 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) study

Kazuomi Kario, Satoshi Hoshide, Motohiro Shimizu et al. · Journal of Hypertension · 2010 · 120 citations

Medicine, Cardiology, Pharmacology +17

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 94 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Energetics during embryonic development in kurosoi, Sebastes schlegeli Hilgendorf

George W. Boehlert, Muneharu Kusakari, Motohiro Shimizu et al. · Journal of Experimental Marine Biology and Ecology · 1986 · 90 citations

Life Sciences, Biology, Developmental Biology +12

Sleep Blood Pressure Self‐Measured at Home as a Novel Determinant of Organ Damage: Japan Morning Surge Home Blood Pressure (J‐<scp>HOP</scp>) Study

Kazuomi Kario, Satoshi Hoshide, Hajime Haimoto et al. · Journal of Clinical Hypertension · 2015 · 75 citations · Full text

Medicine, Cardiology, Internal Medicine +15